12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersChromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. The company's market cap stands at $8.7 million. Kineta (NASDAQ:KA) stock moved upwards
BenzingaApr 19 08:08 ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersBio-Path Hldgs (NASDAQ:BPTH) shares increased by 43.8% to $4.66 during Thursday's pre-market session. The market value of their outstanding shares is at $3.5 million. SINTX Techs (NASDAQ:SINT)
BenzingaApr 18 08:09 ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersTrevena (NASDAQ:TRVN) shares increased by 27.0% to $0.51 during Wednesday's after-market session. The company's market cap stands at $9.2 million. Mustang Bio (NASDAQ:MBIO) stock increased by 1
BenzingaApr 17 16:31 ET
Trevena Is Maintained at Buy by HC Wainwright & Co.
Trevena Is Maintained at Buy by HC Wainwright & Co.
Dow JonesApr 2 08:55 ET
Express News | HC Wainwright & Co. Maintains Buy on Trevena, Maintains $9 Price Target
Moomoo 24/7Apr 2 08:44 ET
Buy Rating Affirmed on Trevena as Focus Shifts to Promising Drug Candidate TRV045
TipRanksApr 2 06:26 ET
Buy Rating Affirmed for Trevena Amid Strategic Focus on Promising TRV045 Development
TipRanksApr 1 13:35 ET
Recap: Trevena Q4 Earnings
Trevena (NASDAQ:TRVN) reported its Q4 earnings results on Monday, April 1, 2024 at 07:00 AM.Here's what investors need to know about the announcement.EarningsTrevena missed estimated earnings by -179.
BenzingaApr 1 09:40 ET
Express News | Trevena Q4 EPS $(1.06) Misses $(0.38) Estimate, Cash Balance of $33M
Moomoo 24/7Apr 1 07:14 ET
Press Release: Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important milestones in both non-clinical
Dow JonesApr 1 07:00 ET
Trevena 4Q Loss $16.5M >TRVN
Trevena 4Q Loss $16.5M >TRVN
Dow JonesApr 1 07:00 ET
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
Stockhouse Apr 1 07:00 ET
Trevena Inc Unveils Updated Corporate Strategy Presentation
TipRanksApr 1 06:12 ET
12 Health Care Stocks Moving In Friday's After-Market Session
GainersSalarius Pharmaceuticals (NASDAQ:SLRX) shares rose 33.9% to $0.83 during Friday's after-market session. The market value of their outstanding shares is at $3.2 million. Masimo (NASDAQ:MASI) sha
BenzingaMar 22 17:33 ET
Express News | HC Wainwright & Co. Reiterates Buy on Trevena, Maintains $9 Price Target
Moomoo 24/7Mar 11 06:50 ET
Trevena Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/11/2024 1536.36% HC Wainwright & Co. → $9 Reiterates Buy → Buy 05/17/2023 263.64% JMP Securities → $2 R
BenzingaMar 11 06:49 ET
Analysts Offer Insights on Healthcare Companies: Trevena (TRVN), MoonLake Immunotherapeutics (MLTX) and Senseonics Holdings (SENS)
TipRanksMar 11 06:40 ET
Trevena Faces Nasdaq Delisting Over Share Price
InvestingMar 6 17:18 ET
Trevena Granted US Patent 11,912,693 Titled 'Compounds For Modulating S1P1 Activity And Methods Of Using The Same'
Trevena Granted US Patent 11,912,693 Titled 'Compounds For Modulating S1P1 Activity And Methods Of Using The Same'
BenzingaFeb 27 12:43 ET
Express News | Trevena Has Been Granted U.S. Patent 11,912,713 Titled "7-membered Aza-Heterocyclic Containing Delta-Opioid Receptor Modulating Compounds, Methods Of Using And Making (For Treating Pain, Migraines, Depression, Parkinsons Disease, And Other Disorders)
Moomoo 24/7Feb 27 12:33 ET
No Data
No Data